NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of argenx SE ("argenx" or the "Company") (NASDAQ:ARGX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether argenx and certain of its officers and/or directors have […]
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE:CTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CTO and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of National Grid plc ("National Grid" or the "Company") (NYSE:NGG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether National Grid and certain of its
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The J.M. Smucker Company ("Smucker" or the "Company") (NYSE:SJM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. ("MarineMax" or the "Company") (NYSE:HZO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MarineMax and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lockheed Martin Corporation ("Lockheed" or the "Company") (NYSE:LMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lockheed and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Telix and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CapricorTherapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 25-cv-00734,
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company") (NASDAQ:PEPG) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-03221,